|
For the Three Months
Ended September 30, |
For the Nine Months
Ended September 30, | |||||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||||
| Non-GAAP Net Loss: | ||||||||||||||||
| Net loss | $ | (12,010 | ) | $ | (15,041 | ) | $ | (56,912 | ) | $ | (51,585 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Depreciation and amortization(1) | 2,478 | 1,909 | 7,939 | 5,716 | ||||||||||||
| Stock-based compensation(2) | 5,730 | 5,113 | 16,222 | 14,048 | ||||||||||||
| Amortization of lease intangible | 180 | 333 | 770 | 999 | ||||||||||||
| Amortization of deferred costs on convertible notes | 466 | 469 | 1,396 | 1,250 | ||||||||||||
| Loss on marketable securities | — | 469 | — | 1,659 | ||||||||||||
| Acquisition and other (4) | 117 | 42 | 343 | (1,242 | ) | |||||||||||
| Loss on sale of property and equipment | — | — | 92 | 71 | ||||||||||||
| Charitable contribution of common stock | 326 | 987 | 696 | 2,272 | ||||||||||||
| Lease abandonment and termination (3) | — | — | 8,778 | — | ||||||||||||
| Impairment of assets | 151 | 325 | 397 | 444 | ||||||||||||
| Restructuring charge (5) | — | — | 738 | — | ||||||||||||
| Costs to exit the supplies business | — | — | 586 | — | ||||||||||||
| Non-GAAP Net Loss | $ | (2,562 | ) | $ | (5,394 | ) | $ | (18,955 | ) | $ | (26,368 | ) | ||||
| Weighted-average number of shares outstanding used to
compute Non-GAAP Net Loss per share, basic and diluted, of Class A and Class B common stock | 47,989,277 | 47,303,090 | 47,852,671 | 47,057,521 | ||||||||||||
| EPS, basic and diluted, of Class A and Class B common
stock | $ | (0.25 | ) | $ | (0.32 | ) | $ | (1.19 | ) | $ | (1.10 | ) | ||||
| Non-GAAP EPS, basic and diluted, of Class A and Class B
common stock | $ | (0.05 | ) | $ | (0.11 | ) | $ | (0.40 | ) | $ | (0.56 | ) | ||||
Xometry Reports Third Quarter 2023 Results
 |  | More MCAD News
|
|
RELATED NEWS
